Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, have announced a clinical development collaboration. The partnership will evaluate the investigational tyrosine kinase inhibitor (TKI) zanzalintinib in combination with Merck’s anti-PD-1 therapy KEYTRUDA®…
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL), which provides a continuous range of vision with excellent tolerance…
GE HealthCare (Nasdaq: GEHC) has introduced the Versana Premier™, the latest addition to its Versana ultrasound family. This system is designed to be reliable, affordable, and user-friendly, offering versatile features for healthcare professionals. Equipped with automation and AI-powered productivity tools,…
Genentech, part of the Roche Group, shared encouraging two-year data from the ongoing RAINBOWFISH study at the 29th World Muscle Society Congress (October 8-12, 2024). This study evaluated the efficacy and safety of Evrysdi® (risdiplam) in children with spinal muscular…
Foundation Medicine, Inc. has announced FDA approval for FoundationOne® Liquid CDx as a companion diagnostic for Itovebi™ (inavolisib) when used with palbociclib (Ibrance®) and fulvestrant. This therapy, developed by Genentech, is designed for adult patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive,…
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis. This treatment is designed to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients aged…
Transverse Medical, Inc., known for its POINT-GUARD™ Cerebral Embolic Protection device, is excited to announce the appointment of Ian T. Meredith, MD, to its Board of Directors. With over 35 years of experience in cardiology, Professor Meredith has a proven…
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts, including five poster presentations, at the American Society of Nephrology (ASN) Kidney Week 2024, happening in San Diego, CA from October 23-27. These findings emphasize the clinical significance of…
VISIE Inc., formerly Advanced Scanners, has successfully showcased Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) at its headquarters in Austin, TX. Continuous Anatomic Auto Tracking (CAAT) CAAT is a groundbreaking technology that enhances surgical robotic and…
Reproductive Medicine Associates (RMA), a leading provider in reproductive services and a pioneer in IVF research, proudly celebrated its 25th anniversary this month. Over the past quarter-century, RMA has made significant contributions to fertility preservation and infertility treatments, driving innovations…
Melt Pharmaceuticals, Inc., a clinical-stage company focused on innovative procedural sedation solutions, has announced the dosing of the last patient in its pivotal Phase 3 study of MELT-300, a non-IV, non-opioid tablet designed for procedural sedation during cataract surgery. MELT-300…
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company known for its UroShield®, PainShield®, and WoundShield® Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices, has announced a non-binding term sheet for a licensing and supply agreement with APOGEPHA Arzneimittel GmbH, a…